Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lakshminarayan

Showing results (571-580 of 585) with videos related to

Pageof 59
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2016
The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive FunctionAnne M Murray, Elizabeth J Bell, David E Tupper, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Biliverdin Reductase A is a major determinant of neuroprotective Nrf2 signalingChirag Vasavda, Ruchita Kothari, Navneet Ammal Kaidery, et al.
Frontiers in Oncology|October 3, 2022
Genomic landscape of advanced prostate cancer patients with <i>BRCA1</i> versus <i>BRCA2</i> mutations as detected by comprehensive genomic profiling of cell-free DNAUmang Swami, Raquel Mae Zimmerman, Roberto H Nussenzveig, et al.
Maedica|July 5, 2021
MyrliMax® and Low Back Pain: A Multicentric, Observational, Post-Marketing Surveillance Study in Indian Patients Suffering from Chronic Low Back Pain of Various Pain IntensityVarun Sureja, Dharmeshkumar Kheni, Divyanshu Prajapati, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2025
Biliverdin reductase A is a major determinant of protective NRF2 signalingChirag Vasavda, Ruchita Kothari, Navneet Ammal Kaidery, et al.
Kidney International|March 30, 2021
A multicenter randomized controlled trial indicates that paclitaxel-coated balloons provide no benefit for arteriovenous fistulasNarayan Karunanithy, Emily J Robinson, Farhan Ahmad, et al.
Molecular Cell|August 22, 2025
Expanding the druggable zinc-finger proteome defines properties of drug-induced degradationMikołaj Słabicki, Jiho Park, Radosław P Nowak, et al.
Journal of Inherited Metabolic Disease|October 15, 2019
Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuriaLakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
JAMA Neurology|May 12, 2015
Rare and Coding Region Genetic Variants Associated With Risk of Ischemic Stroke: The NHLBI Exome Sequence ProjectPaul L Auer, Mike Nalls, James F Meschia, et al.
European Journal of Human Genetics : EJHG|March 26, 2015
Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on 'black bone disease' in ItalyMartina Nemethova, Jan Radvanszky, Ludevit Kadasi, et al.
Pageof 59

Showing results (571-580 of 585) with videos related to

Sort By:
Pageof 59
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2016
The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive FunctionAnne M Murray, Elizabeth J Bell, David E Tupper, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Biliverdin Reductase A is a major determinant of neuroprotective Nrf2 signalingChirag Vasavda, Ruchita Kothari, Navneet Ammal Kaidery, et al.
Frontiers in Oncology|October 3, 2022
Genomic landscape of advanced prostate cancer patients with <i>BRCA1</i> versus <i>BRCA2</i> mutations as detected by comprehensive genomic profiling of cell-free DNAUmang Swami, Raquel Mae Zimmerman, Roberto H Nussenzveig, et al.
Maedica|July 5, 2021
MyrliMax® and Low Back Pain: A Multicentric, Observational, Post-Marketing Surveillance Study in Indian Patients Suffering from Chronic Low Back Pain of Various Pain IntensityVarun Sureja, Dharmeshkumar Kheni, Divyanshu Prajapati, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2025
Biliverdin reductase A is a major determinant of protective NRF2 signalingChirag Vasavda, Ruchita Kothari, Navneet Ammal Kaidery, et al.
Kidney International|March 30, 2021
A multicenter randomized controlled trial indicates that paclitaxel-coated balloons provide no benefit for arteriovenous fistulasNarayan Karunanithy, Emily J Robinson, Farhan Ahmad, et al.
Molecular Cell|August 22, 2025
Expanding the druggable zinc-finger proteome defines properties of drug-induced degradationMikołaj Słabicki, Jiho Park, Radosław P Nowak, et al.
Journal of Inherited Metabolic Disease|October 15, 2019
Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuriaLakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
JAMA Neurology|May 12, 2015
Rare and Coding Region Genetic Variants Associated With Risk of Ischemic Stroke: The NHLBI Exome Sequence ProjectPaul L Auer, Mike Nalls, James F Meschia, et al.
European Journal of Human Genetics : EJHG|March 26, 2015
Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on 'black bone disease' in ItalyMartina Nemethova, Jan Radvanszky, Ludevit Kadasi, et al.
Pageof 59